Nick Leschly
2019 - bluebird bio
In 2019, Nick Leschly earned a total compensation of $13.2M as Chief Executive Officer at bluebird bio, a 45% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $418,275 |
---|---|
Option Awards | $8,698,341 |
Salary | $660,000 |
Stock Awards | $3,365,750 |
Other | $11,200 |
Total | $13,153,566 |
Leschly received $8.7M in option awards, accounting for 66% of the total pay in 2019.
Leschly also received $418.3K in non-equity incentive plan, $660K in salary, $3.4M in stock awards and $11.2K in other compensation.
Rankings
In 2019, Nick Leschly's compensation ranked 445th out of 13,971 executives tracked by ExecPay. In other words, Leschly earned more than 96.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 445 | 97th |
Manufacturing | 166 | 97th |
Chemicals And Allied Products | 44 | 98th |
Drugs | 36 | 98th |
Biological Products, Except Diagnostic Substances | 7 | 98th |
Leschly's colleagues
We found five more compensation records of executives who worked with Nick Leschly at bluebird bio in 2019.
News
2seventy bio CEO Nick Leschly's 2023 pay jumps 49% to $9.1M
April 25, 2024
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
2seventy bio CEO Nick Leschly's 2021 pay rises 1% to $6.3M
April 26, 2022
bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
April 27, 2020
bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
April 23, 2019